The Novartis Institutes for BioMedical Research (NIBR) is the global pharmaceutical research organization of Novartis. It has approximately 6 000 scientists and physicians around the world. Its research is focused on discovering innovative new drugs that will change the practice of medicine. NIBR is located at Cambridge, Massachusetts; Emeryville, CA; Basel, Switzerland; Horsham, UK; and Shanghai, China. Our Cambridge, MA, location is the global research headquarters and has focuses in areas including Pathway Biology, Oncology, Ophthalmology, Metabolism, Muscle, Epigenetics, and Regenerative Medicine. It has a variety of positions in Biology, Chemistry, Biologics, Protein Sciences, and other technologies and additionally in functions such as Patents, Computational Resources, Alliance Management, Operations and other areas that support our scientific resources.
The strength of the institute lies in its ability to produce the true, genuine and unique research works where its students and staff pursue research and academics with passion and at most dedication. The Novartis Institute is counted among world’s top research institute for pharmaceutical research with more than 6000 scientists which have their expertise in that field.